Compare JFIN & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JFIN | NAUT |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.9M | 338.5M |
| IPO Year | 2018 | 2020 |
| Metric | JFIN | NAUT |
|---|---|---|
| Price | $6.57 | $2.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 70.3K | ★ 205.8K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | ★ 11.98% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.73 | $0.62 |
| 52 Week High | $18.70 | $3.08 |
| Indicator | JFIN | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 50.65 | 50.65 |
| Support Level | $6.42 | $1.82 |
| Resistance Level | $7.22 | N/A |
| Average True Range (ATR) | 0.34 | 0.28 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 83.75 | 37.87 |
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.